Nanda R - Search Results

1

The impact of site-specific digital histology signatures on deep learning model accuracy and bias.

Howard FM, Dolezal J, Kochanny S, Schulte J, Chen H, Heij L, Huo D, Nanda R, Olopade OI, Kather JN, Cipriani N, Grossman RL, Pearson AT. Howard FM, et al. Among authors: nanda r. Nat Commun. 2021 Jul 20;12(1):4423. doi: 10.1038/s41467-021-24698-1. Nat Commun. 2021. PMID: 34285218 Free PMC article.

2

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI. Nanda R, et al. JAMA. 2005 Oct 19;294(15):1925-33. doi: 10.1001/jama.294.15.1925. JAMA. 2005. PMID: 16234499

3

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, Xu J, Fackenthal J, Tretiakova M, Das S, Olopade OI. Wei M, et al. Among authors: nanda r. Cancer Res. 2005 Dec 1;65(23):10692-9. doi: 10.1158/0008-5472.CAN-05-1277. Cancer Res. 2005. PMID: 16322213

4

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM. Livasy CA, et al. Among authors: nanda r. Mod Pathol. 2006 Feb;19(2):264-71. doi: 10.1038/modpathol.3800528. Mod Pathol. 2006. PMID: 16341146 Free article.

5

Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.

Wei M, Xu J, Dignam J, Nanda R, Sveen L, Fackenthal J, Grushko TA, Olopade OI. Wei M, et al. Among authors: nanda r. Breast Cancer Res Treat. 2008 Sep;111(1):113-20. doi: 10.1007/s10549-007-9766-6. Epub 2007 Oct 12. Breast Cancer Res Treat. 2008. PMID: 17932744 Free PMC article.

6

Advances in breast cancer: pathways to personalized medicine.

Olopade OI, Grushko TA, Nanda R, Huo D. Olopade OI, et al. Among authors: nanda r. Clin Cancer Res. 2008 Dec 15;14(24):7988-99. doi: 10.1158/1078-0432.CCR-08-1211. Clin Cancer Res. 2008. PMID: 19088015 Free PMC article. Review.

7

Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.

Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, Falusi A, Perou CM, Olopade OI. Huo D, et al. Among authors: nanda r. J Clin Oncol. 2009 Sep 20;27(27):4515-21. doi: 10.1200/JCO.2008.19.6873. Epub 2009 Aug 24. J Clin Oncol. 2009. PMID: 19704069 Free PMC article.

8

Phase II trial of temsirolimus in patients with metastatic breast cancer.

Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Fleming GF, et al. Among authors: nanda r. Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13. Breast Cancer Res Treat. 2012. PMID: 22245973 Free PMC article. Clinical Trial.

9

The role of tumor-associated macrophages in breast cancer progression (review).

Obeid E, Nanda R, Fu YX, Olopade OI. Obeid E, et al. Among authors: nanda r. Int J Oncol. 2013 Jul;43(1):5-12. doi: 10.3892/ijo.2013.1938. Epub 2013 May 14. Int J Oncol. 2013. PMID: 23673510 Free PMC article. Review.

10

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.

O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, Merkel DE, Peppercorn JM, Rugo HS, Dees EC, Hahn OM, Hoffman PC, Rosner GL, Huang RS, Ratain MJ, Cox N, Olopade OI, Wolff AC, Dolan ME, Nanda R; Translational Breast Cancer Research Consortium (TBCRC). O'Donnell PH, et al. Among authors: nanda r. Breast Cancer Res Treat. 2020 Jun;181(3):623-633. doi: 10.1007/s10549-020-05603-8. Epub 2020 May 6. Breast Cancer Res Treat. 2020. PMID: 32378051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

797 results

Search Page